Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2-4 mg for weight management

Synopsis
Scientific article exploring the results and analysis of a randomized, controlled Phase IB trial conducted by Altasciences and Novo Nordisk A/S published on The Lancet.
URL
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00845-X/fulltext
Date of publication
April 22, 2021
Category